Open Ac ce s s Correspondence : Osteonecrosis in childhood acute lymphoblastic leukemia : a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology ( AIEOP )

Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP) Rosanna Parasole, Maria G. Valsecchi, Daniela Silvestri, Franco Locatelli, Elena Barisone, Fara Petruzziello, M. Caterina Putti, Concetta Micalizzi, Antonella Colombini, Rossella Mura, Tommaso Mina, Anna M. Testi, Lucia D. Notarangelo, Nicola Santoro, Tommaso Casini, Caterina Consarino, Luca Lo Nigro, Ottavio Ziino, Giovanna Giagnuolo, Carmelo Rizzari and Valentino Conter

[1]  A. Borkhardt,et al.  Osteonecrosis in children with acute lymphoblastic leukemia , 2016, Haematologica.

[2]  M. Loh,et al.  Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Harbott,et al.  Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. , 2016, Blood.

[4]  D. Little,et al.  Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL) , 2016, Cancer medicine.

[5]  M. Loh,et al.  Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. , 2015, Blood.

[6]  J. Downing,et al.  Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Relling,et al.  Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. , 2014, European journal of cancer.

[8]  D. Little,et al.  Use of zoledronic acid for treatment of chemotherapy related osteonecrosis in children and adolescents: A retrospective analysis , 2013, Pediatric blood & cancer.

[9]  P. Auquier,et al.  Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood , 2013, Haematologica.

[10]  J. Nachman.  Osteonecrosis in childhood ALL. , 2011, Blood.

[11]  M. Relling,et al.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. , 2010, Blood.

[12]  M. Schrappe,et al.  Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL‐BFM 95 , 2005, Pediatric blood & cancer.

[13]  R. Sposto,et al.  Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. , 2001, Medical and pediatric oncology.

[14]  H. Sather,et al.  Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .